Thank you for joining us in 2022!

Program (At a Glance)

Day 1

Cancer Immunotherapy Basics: Harnessing Our Immune System to Fight Cancer

Jennifer Wargo, MD, MMSc
Professor, Dept. of Genomic Medicine, Division of Cancer Medicine
Professor, Dept. of Surgical Oncology, Division of Surgery
The University of Texas MD Anderson Cancer Center
Houston, TX

Clinical Trials and Cancer Immunotherapy: Accessing Promising Treatments

Peter E. Fecci, MD, PhD
Neurosurgeon and Director, Duke Brain Tumor Immunotherapy Program
Duke Cancer Center, DukeHealth, and Duke University
Durham, NC

Patient Perspectives: Immunotherapy and Clinical Trial Experiences

Hear three cancer patients treated with immunotherapy share their stories of learning about this new approach to cancer treatment and how it is different from other types of cancer treatment, clinical trials, and family and community support while they navigate their patient journeys at the vanguard of cancer treatment.

  • Stephanie Gangi, breast cancer navigator
  • Sunshine Pegues, lung cancer veteran
  • John White, prostate cancer veteran
  • Brian Brewer, moderator
 

Expert-Led Breakout Sessions: How Immunotherapy Works for Different Cancer Types

Bladder Cancer Immunotherapy

Matthew D. Galsky, MD
Professor of Medicine (Hematology and Oncology)
Director of Genitourinary Medical Oncology
Co-Director, Center of Excellence for Bladder Cancer
Associate Director, Translational Research
The Tisch Cancer Institute, Mount Sinai
New York, NY

Gynecologic Cancer Immunotherapy

Kunle Odunsi, MD, PhD, FRCOG, FACOG
AbbVie Foundation Distinguished Professor of Obstetrics and Gynecology
Professor of Medicine
Director of UChicago Comprehensive Cancer Research Center
Dean for Oncology, Biological Sciences Division
Director, UChicago Medicine Comprehensive Cancer Center
Chicago, IL

Liver Cancer Immunotherapy

Theodore H. Welling, MD
Director, Liver Cancer Program
Leader, Liver Cancer Immuno-Oncology and Clinical Trials
Perlmutter Cancer Center
NYU Langone Health
New York, NY

Skin Cancer and Melanoma Immunotherapy

Jeffrey S. Weber, MD, PhD
Laura and Isaac Perlmutter Professor of Oncology, Dept. of Medicine,
NYU Grossman School of Medicine
Deputy Director, Perlmutter Cancer Center
Co-Director, Melanoma Research Program
NYU Langone Health
New York, NY


Day 2

Understanding and Overcoming Barriers to Accessing Cancer Care

Our panel will address racial, ethnic, socioeconomic, and other factors that impact access to information about cancer immunotherapy and cancer care, building community trust, and the need to increase diversity among clinical trial participants.

Ana I. Velázquez Mañana, MD MSc
Assistant Professor of Medicine
UCSF at ZSFG Division of Hematology/Oncology
Assistant Director of DEIA for Training
UCSF Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, CA

LaToya Bolds-Johnson, PA-C, CAQ-EM
Board-Certified Physician Assistant
Medical Advisor, Patient Advocate
Medical & Biotechnology Consultant
Breast Cancer Advocate & Thriver
Washington, DC

Stephen Estrada
Patient Advocate
Long-term Survivor of Stage 4 Colorectal Cancer
Las Vegas, NV

Joseph E. Ravenell, MD (moderator)
Associate Professor, Departments of Population Health & Medicine
NYU Grossman School of Medicine
Perlmutter Cancer Center at NYU Langone
NYU Langone Health
New York, NY


Expert-Led Breakout Sessions: How Immunotherapy Works for Different Cancer Types

Blood Cancer Immunotherapy

Marcel van den Brink, MD, PhD
Head, Division of Hematologic Malignancies
Alan Houghton Chair in Immunology
Memorial Sloan Kettering Cancer Center
New York, NY

Breast Cancer Immunotherapy

Elizabeth Ann Mittendorf, MD, PhD
Rob and Karen Hale Distinguished Chair in Surgical Oncology, Brigham and Women’s Hospital
Director, Surgical Research
Director, Breast Immuno-Oncology Program
Co-Director, Breast Cancer Clinical Research Program
Physician and Professor of Surgery, Harvard Medical School
Boston, MA

Colorectal Cancer Immunotherapy

Luis Diaz Jr., MD
Head of the Division of Solid Tumor Oncology;
Grayer Family Chair

and

Andrea Cercek, MD
Section Head, Rectal Cancer; Anal Cancer; Appendiceal Cancer;
Young Onset Colorectal Cancer; Cholangiosarcoma
Memorial Sloan Kettering Cancer Center
New York, NY

Kidney Cancer Immunotherapy

Sangeeta Goswami, MD, PhD
Assistant Professor, Dept. of Genitourinary Medical Oncology
Division of Cancer Medicine
Assistant Professor, Dept. of Immunology
Division of Basic Science Research
The University of Texas MD Anderson Cancer Center
Houston, TX

Lung Cancer Immunotherapy

Julie Brahmer, MD
Co-Director of the Upper Aerodigestive Department
Bloomberg~Kimmel Institute for Cancer Immunotherapy
Professor of Oncology
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD

Pancreatic Cancer Immunotherapy

Robert H. Vonderheide, MD, DPhil
Attending Physician, Hospital of the University of Pennsylvania
Director, Abramson Cancer Center and Abramson Family Cancer Research Institute
Vice Dean and Vice President, Cancer Programs
University of Pennsylvania Health System
Philadelphia, PA

Prostate Cancer Immunotherapy

Lawrence Fong, MD
Efim Guzik Distinguished Professor in Cancer Biology, UCSF
Leader, Cancer Immunotherapy Program, and Co-Leader,
Cancer Immunology and Immunotherapy Program
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA